Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
-
861
-
862
-
863
Summary of post-treatment disease course measures from off-label medications clinical trials.
Published 2025Subjects: -
864
Summary of post-treatment CAPS score changes from clinical trials with psychotherapies.
Published 2025Subjects: -
865
Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes.
Published 2025Subjects: -
866
Summary of post-treatment disease course measures from clinical trials with psychotherapies.
Published 2025Subjects: -
867
-
868
-
869
Post-treatment CAPS score changes from clinical trials with off-label PTSD medications.
Published 2025Subjects: -
870
-
871
-
872
Training impact on electrical properties of P3 lumbar MNs. Rin: input resistance. Rheobase: lowest intensity of current injected in MNs to elicit an action potential (AP). AP threshold: voltage measured at the foot of the AP. AP amplitude: measured between the resting membrane potential and the AP peak. AP half width: time spent by the potential > 50% of the AP maximum amplitude. AP rise time: time spent by the potential between 10% and 90% of the AP maximum amplitude. AP half decay time: time spent by the potential between the AP maximum amplitude and the 50% decreasing amplitude. ADP: after-depolarization potential. All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different....
Published 2025“…All values are means ± SEM. The number of MNs recorded is indicated between brackets. ns: no significantly different. …”
-
873
BFD2 exacerbates the inflammation induced in the acute stage of <i>T. gondii</i> infection.
Published 2025Subjects: -
874
-
875
HFD decreases ITM and alters metabolic homeostasis.
Published 2025“…The TAG accumulated in the whole body significantly increased under the HFD condition compared to the ND condition. …”
-
876
-
877
-
878
-
879
IRE1 silencing downregulates cell cycle genes and engages TP53 and specific CDK inhibitors.
Published 2025Subjects: -
880
Identification and validation of <i>Ctsz</i> as the lead candidate gene underlying <i>Tip5.</i>
Published 2025Subjects: